Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: A multicentre study

Clinical Microbiology and Infection

Volumn 17, Issue 8, 2011, Pages 1166-1179

  Baldanti, F ^a   Campanini, G ^a   Piralla, A ^a   Rovida, F ^a   Braschi, A ^a   Mojoli, F ^a   Iotti, G ^a   Belliato, M ^a   Conaldi, P G ^b   Arcadipane, A ^b   Pariani, E ^c   Zanetti, A ^c   Minoli, L ^d   Emmi, V ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b ISSMET   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

222G N variants; Bronchoalveolar lavage; Influenza A H1N1 09v; Intensive care unit; Virulence

Indexed keywords

VIRUS HEMAGGLUTININ;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHILD; COMMUNITY CARE; CONTROLLED STUDY; DISEASE DURATION; EXTRACORPOREAL OXYGENATION; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HOSPITAL PATIENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTICENTER STUDY; NOSE SMEAR; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 79551574132     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03403.x     Document Type: Article

References (11)

1. World Health Organization. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A(H1N1) 2009 viruses. Wkly Epidemiol Rec 2010; 85: 21-22.
2. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 2010; 15: 19498.
3. Mak GC, Au KW, Tai LS et al. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 2010; 15: 19534.
4. Miller RS, MacLean AR, Gunson RN, Carman WF. Occurrence of hemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 2010; 15: 19546.
5. Anton A, Marcos MA, Martinez MJ et al. D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. Diagn Microbiol Infect Dis 2010; 67: 207-208.
6. Zarychanski R, Stuart TL, Kumar A et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182: 257-264.
7. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanism, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
8. Paolucci S, Baldanti F, Campanini G et al. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients. J Med Virol 2001; 65: 207-217.
9. Shen J, Ma J, Wang Q. Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918. PLoS ONE 2009; 4: e7789.
10. Newhouse EI, Xu D, Markwick PR et al. Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective. J Am Chem Soc 2009; 131: 17430-17442.
11. Puzelli S, Facchini M, Spagnolo D et al. Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis 2010; 16: 863-865.